img

Global Lung Disease Therapeutic Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Lung Disease Therapeutic Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Lung Disease Therapeutic Market
Global Lung Disease Therapeutic market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Lung Disease Therapeutic industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Lung Disease Therapeutic market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Lung Disease Therapeutic market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


GSK
AstraZeneca
Boehringer Ingelheim
Novartis
Mylan
Vertex Pharmaceuticals
F. Hoffman La Roche
Teva Pharmaceuticals
Cipla
Fibrogen
Liminal Biosciences
PharmAkea Therapeutics
IQVIA
Segment by Type
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Lung Cancer
Other

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Lung Disease Therapeutic introduction, etc. Lung Disease Therapeutic Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Lung Disease Therapeutic
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Disease Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Asthma
1.2.3 Chronic Obstructive Pulmonary Disease (COPD)
1.2.4 Lung Cancer
1.2.5 Other
1.3 Market by Application
1.3.1 Global Lung Disease Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Disease Therapeutic Market Perspective (2018-2033)
2.2 Global Lung Disease Therapeutic Growth Trends by Region
2.2.1 Lung Disease Therapeutic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Lung Disease Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Lung Disease Therapeutic Forecasted Market Size by Region (2024-2033)
2.3 Lung Disease Therapeutic Market Dynamics
2.3.1 Lung Disease Therapeutic Industry Trends
2.3.2 Lung Disease Therapeutic Market Drivers
2.3.3 Lung Disease Therapeutic Market Challenges
2.3.4 Lung Disease Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Lung Disease Therapeutic by Players
3.1.1 Global Lung Disease Therapeutic Revenue by Players (2018-2023)
3.1.2 Global Lung Disease Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Lung Disease Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Lung Disease Therapeutic, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Lung Disease Therapeutic Market Concentration Ratio
3.4.1 Global Lung Disease Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Disease Therapeutic Revenue in 2022
3.5 Global Key Players of Lung Disease Therapeutic Head office and Area Served
3.6 Global Key Players of Lung Disease Therapeutic, Product and Application
3.7 Global Key Players of Lung Disease Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Disease Therapeutic Breakdown Data by Type
4.1 Global Lung Disease Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Lung Disease Therapeutic Forecasted Market Size by Type (2024-2033)
5 Lung Disease Therapeutic Breakdown Data by Application
5.1 Global Lung Disease Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Lung Disease Therapeutic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Lung Disease Therapeutic Market Size (2018-2033)
6.2 North America Lung Disease Therapeutic Market Size by Type
6.2.1 North America Lung Disease Therapeutic Market Size by Type (2018-2023)
6.2.2 North America Lung Disease Therapeutic Market Size by Type (2024-2033)
6.2.3 North America Lung Disease Therapeutic Market Share by Type (2018-2033)
6.3 North America Lung Disease Therapeutic Market Size by Application
6.3.1 North America Lung Disease Therapeutic Market Size by Application (2018-2023)
6.3.2 North America Lung Disease Therapeutic Market Size by Application (2024-2033)
6.3.3 North America Lung Disease Therapeutic Market Share by Application (2018-2033)
6.4 North America Lung Disease Therapeutic Market Size by Country
6.4.1 North America Lung Disease Therapeutic Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Lung Disease Therapeutic Market Size by Country (2018-2023)
6.4.3 North America Lung Disease Therapeutic Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Lung Disease Therapeutic Market Size (2018-2033)
7.2 Europe Lung Disease Therapeutic Market Size by Type
7.2.1 Europe Lung Disease Therapeutic Market Size by Type (2018-2023)
7.2.2 Europe Lung Disease Therapeutic Market Size by Type (2024-2033)
7.2.3 Europe Lung Disease Therapeutic Market Share by Type (2018-2033)
7.3 Europe Lung Disease Therapeutic Market Size by Application
7.3.1 Europe Lung Disease Therapeutic Market Size by Application (2018-2023)
7.3.2 Europe Lung Disease Therapeutic Market Size by Application (2024-2033)
7.3.3 Europe Lung Disease Therapeutic Market Share by Application (2018-2033)
7.4 Europe Lung Disease Therapeutic Market Size by Country
7.4.1 Europe Lung Disease Therapeutic Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Lung Disease Therapeutic Market Size by Country (2018-2023)
7.4.3 Europe Lung Disease Therapeutic Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Lung Disease Therapeutic Market Size (2018-2033)
8.2 China Lung Disease Therapeutic Market Size by Type
8.2.1 China Lung Disease Therapeutic Market Size by Type (2018-2023)
8.2.2 China Lung Disease Therapeutic Market Size by Type (2024-2033)
8.2.3 China Lung Disease Therapeutic Market Share by Type (2018-2033)
8.3 China Lung Disease Therapeutic Market Size by Application
8.3.1 China Lung Disease Therapeutic Market Size by Application (2018-2023)
8.3.2 China Lung Disease Therapeutic Market Size by Application (2024-2033)
8.3.3 China Lung Disease Therapeutic Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Lung Disease Therapeutic Market Size (2018-2033)
9.2 Asia Lung Disease Therapeutic Market Size by Type
9.2.1 Asia Lung Disease Therapeutic Market Size by Type (2018-2023)
9.2.2 Asia Lung Disease Therapeutic Market Size by Type (2024-2033)
9.2.3 Asia Lung Disease Therapeutic Market Share by Type (2018-2033)
9.3 Asia Lung Disease Therapeutic Market Size by Application
9.3.1 Asia Lung Disease Therapeutic Market Size by Application (2018-2023)
9.3.2 Asia Lung Disease Therapeutic Market Size by Application (2024-2033)
9.3.3 Asia Lung Disease Therapeutic Market Share by Application (2018-2033)
9.4 Asia Lung Disease Therapeutic Market Size by Region
9.4.1 Asia Lung Disease Therapeutic Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Lung Disease Therapeutic Market Size by Region (2018-2023)
9.4.3 Asia Lung Disease Therapeutic Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Lung Disease Therapeutic Introduction
11.1.4 GSK Revenue in Lung Disease Therapeutic Business (2018-2023)
11.1.5 GSK Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Lung Disease Therapeutic Introduction
11.2.4 AstraZeneca Revenue in Lung Disease Therapeutic Business (2018-2023)
11.2.5 AstraZeneca Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Lung Disease Therapeutic Introduction
11.3.4 Boehringer Ingelheim Revenue in Lung Disease Therapeutic Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Lung Disease Therapeutic Introduction
11.4.4 Novartis Revenue in Lung Disease Therapeutic Business (2018-2023)
11.4.5 Novartis Recent Developments
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Lung Disease Therapeutic Introduction
11.5.4 Mylan Revenue in Lung Disease Therapeutic Business (2018-2023)
11.5.5 Mylan Recent Developments
11.6 Vertex Pharmaceuticals
11.6.1 Vertex Pharmaceuticals Company Details
11.6.2 Vertex Pharmaceuticals Business Overview
11.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Introduction
11.6.4 Vertex Pharmaceuticals Revenue in Lung Disease Therapeutic Business (2018-2023)
11.6.5 Vertex Pharmaceuticals Recent Developments
11.7 F. Hoffman La Roche
11.7.1 F. Hoffman La Roche Company Details
11.7.2 F. Hoffman La Roche Business Overview
11.7.3 F. Hoffman La Roche Lung Disease Therapeutic Introduction
11.7.4 F. Hoffman La Roche Revenue in Lung Disease Therapeutic Business (2018-2023)
11.7.5 F. Hoffman La Roche Recent Developments
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Details
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Introduction
11.8.4 Teva Pharmaceuticals Revenue in Lung Disease Therapeutic Business (2018-2023)
11.8.5 Teva Pharmaceuticals Recent Developments
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla Lung Disease Therapeutic Introduction
11.9.4 Cipla Revenue in Lung Disease Therapeutic Business (2018-2023)
11.9.5 Cipla Recent Developments
11.10 Fibrogen
11.10.1 Fibrogen Company Details
11.10.2 Fibrogen Business Overview
11.10.3 Fibrogen Lung Disease Therapeutic Introduction
11.10.4 Fibrogen Revenue in Lung Disease Therapeutic Business (2018-2023)
11.10.5 Fibrogen Recent Developments
11.11 Liminal Biosciences
11.11.1 Liminal Biosciences Company Details
11.11.2 Liminal Biosciences Business Overview
11.11.3 Liminal Biosciences Lung Disease Therapeutic Introduction
11.11.4 Liminal Biosciences Revenue in Lung Disease Therapeutic Business (2018-2023)
11.11.5 Liminal Biosciences Recent Developments
11.12 PharmAkea Therapeutics
11.12.1 PharmAkea Therapeutics Company Details
11.12.2 PharmAkea Therapeutics Business Overview
11.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Introduction
11.12.4 PharmAkea Therapeutics Revenue in Lung Disease Therapeutic Business (2018-2023)
11.12.5 PharmAkea Therapeutics Recent Developments
11.13 IQVIA
11.13.1 IQVIA Company Details
11.13.2 IQVIA Business Overview
11.13.3 IQVIA Lung Disease Therapeutic Introduction
11.13.4 IQVIA Revenue in Lung Disease Therapeutic Business (2018-2023)
11.13.5 IQVIA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Lung Disease Therapeutic Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Asthma
Table 3. Key Players of Chronic Obstructive Pulmonary Disease (COPD)
Table 4. Key Players of Lung Cancer
Table 5. Key Players of Other
Table 6. Global Lung Disease Therapeutic Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Lung Disease Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Lung Disease Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Lung Disease Therapeutic Market Share by Region (2018-2023)
Table 10. Global Lung Disease Therapeutic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Lung Disease Therapeutic Market Share by Region (2024-2033)
Table 12. Lung Disease Therapeutic Market Trends
Table 13. Lung Disease Therapeutic Market Drivers
Table 14. Lung Disease Therapeutic Market Challenges
Table 15. Lung Disease Therapeutic Market Restraints
Table 16. Global Lung Disease Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Lung Disease Therapeutic Revenue Share by Players (2018-2023)
Table 18. Global Top Lung Disease Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Disease Therapeutic as of 2022)
Table 19. Global Lung Disease Therapeutic Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Lung Disease Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Lung Disease Therapeutic, Headquarters and Area Served
Table 22. Global Key Players of Lung Disease Therapeutic, Product and Application
Table 23. Global Key Players of Lung Disease Therapeutic, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lung Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Lung Disease Therapeutic Revenue Market Share by Type (2018-2023)
Table 27. Global Lung Disease Therapeutic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Lung Disease Therapeutic Revenue Market Share by Type (2024-2033)
Table 29. Global Lung Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Lung Disease Therapeutic Revenue Share by Application (2018-2023)
Table 31. Global Lung Disease Therapeutic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Lung Disease Therapeutic Revenue Share by Application (2024-2033)
Table 33. North America Lung Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Lung Disease Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Lung Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Lung Disease Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Lung Disease Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Lung Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Lung Disease Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Lung Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Lung Disease Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Lung Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Lung Disease Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Lung Disease Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Lung Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Lung Disease Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Lung Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Lung Disease Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Lung Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Lung Disease Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Lung Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Lung Disease Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Lung Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Lung Disease Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Lung Disease Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Lung Disease Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Lung Disease Therapeutic Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Lung Disease Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 65. GSK Company Details
Table 66. GSK Business Overview
Table 67. GSK Lung Disease Therapeutic Product
Table 68. GSK Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 69. GSK Recent Developments
Table 70. AstraZeneca Company Details
Table 71. AstraZeneca Business Overview
Table 72. AstraZeneca Lung Disease Therapeutic Product
Table 73. AstraZeneca Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 74. AstraZeneca Recent Developments
Table 75. Boehringer Ingelheim Company Details
Table 76. Boehringer Ingelheim Business Overview
Table 77. Boehringer Ingelheim Lung Disease Therapeutic Product
Table 78. Boehringer Ingelheim Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 79. Boehringer Ingelheim Recent Developments
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Lung Disease Therapeutic Product
Table 83. Novartis Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 84. Novartis Recent Developments
Table 85. Mylan Company Details
Table 86. Mylan Business Overview
Table 87. Mylan Lung Disease Therapeutic Product
Table 88. Mylan Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 89. Mylan Recent Developments
Table 90. Vertex Pharmaceuticals Company Details
Table 91. Vertex Pharmaceuticals Business Overview
Table 92. Vertex Pharmaceuticals Lung Disease Therapeutic Product
Table 93. Vertex Pharmaceuticals Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 94. Vertex Pharmaceuticals Recent Developments
Table 95. F. Hoffman La Roche Company Details
Table 96. F. Hoffman La Roche Business Overview
Table 97. F. Hoffman La Roche Lung Disease Therapeutic Product
Table 98. F. Hoffman La Roche Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 99. F. Hoffman La Roche Recent Developments
Table 100. Teva Pharmaceuticals Company Details
Table 101. Teva Pharmaceuticals Business Overview
Table 102. Teva Pharmaceuticals Lung Disease Therapeutic Product
Table 103. Teva Pharmaceuticals Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 104. Teva Pharmaceuticals Recent Developments
Table 105. Cipla Company Details
Table 106. Cipla Business Overview
Table 107. Cipla Lung Disease Therapeutic Product
Table 108. Cipla Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 109. Cipla Recent Developments
Table 110. Fibrogen Company Details
Table 111. Fibrogen Business Overview
Table 112. Fibrogen Lung Disease Therapeutic Product
Table 113. Fibrogen Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 114. Fibrogen Recent Developments
Table 115. Liminal Biosciences Company Details
Table 116. Liminal Biosciences Business Overview
Table 117. Liminal Biosciences Lung Disease Therapeutic Product
Table 118. Liminal Biosciences Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 119. Liminal Biosciences Recent Developments
Table 120. PharmAkea Therapeutics Company Details
Table 121. PharmAkea Therapeutics Business Overview
Table 122. PharmAkea Therapeutics Lung Disease Therapeutic Product
Table 123. PharmAkea Therapeutics Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 124. PharmAkea Therapeutics Recent Developments
Table 125. IQVIA Company Details
Table 126. IQVIA Business Overview
Table 127. IQVIA Lung Disease Therapeutic Product
Table 128. IQVIA Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 129. IQVIA Recent Developments
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Disease Therapeutic Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Lung Disease Therapeutic Market Share by Type: 2022 VS 2033
Figure 3. Asthma Features
Figure 4. Chronic Obstructive Pulmonary Disease (COPD) Features
Figure 5. Lung Cancer Features
Figure 6. Other Features
Figure 7. Global Lung Disease Therapeutic Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Lung Disease Therapeutic Market Share by Application: 2022 VS 2033
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Lung Disease Therapeutic Report Years Considered
Figure 13. Global Lung Disease Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Lung Disease Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Lung Disease Therapeutic Market Share by Region: 2022 VS 2033
Figure 16. Global Lung Disease Therapeutic Market Share by Players in 2022
Figure 17. Global Top Lung Disease Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Disease Therapeutic as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Lung Disease Therapeutic Revenue in 2022
Figure 19. North America Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Lung Disease Therapeutic Market Share by Type (2018-2033)
Figure 21. North America Lung Disease Therapeutic Market Share by Application (2018-2033)
Figure 22. North America Lung Disease Therapeutic Market Share by Country (2018-2033)
Figure 23. United States Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Lung Disease Therapeutic Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Lung Disease Therapeutic Market Share by Type (2018-2033)
Figure 27. Europe Lung Disease Therapeutic Market Share by Application (2018-2033)
Figure 28. Europe Lung Disease Therapeutic Market Share by Country (2018-2033)
Figure 29. Germany Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Lung Disease Therapeutic Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Lung Disease Therapeutic Market Share by Type (2018-2033)
Figure 37. China Lung Disease Therapeutic Market Share by Application (2018-2033)
Figure 38. Asia Lung Disease Therapeutic Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Lung Disease Therapeutic Market Share by Type (2018-2033)
Figure 40. Asia Lung Disease Therapeutic Market Share by Application (2018-2033)
Figure 41. Asia Lung Disease Therapeutic Market Share by Region (2018-2033)
Figure 42. Japan Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Lung Disease Therapeutic Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Lung Disease Therapeutic Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Lung Disease Therapeutic Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Lung Disease Therapeutic Market Share by Country (2018-2033)
Figure 52. Brazil Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GSK Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 59. AstraZeneca Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 61. Novartis Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 62. Mylan Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 63. Vertex Pharmaceuticals Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 64. F. Hoffman La Roche Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 65. Teva Pharmaceuticals Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 66. Cipla Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 67. Fibrogen Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 68. Liminal Biosciences Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 69. PharmAkea Therapeutics Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 70. IQVIA Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries